SCHEMBL7089786

SCHEMBL7089786

OCc1ccc(OCc2ccccc2)c(Sc2ccc(F)cc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
LMNA P02545 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SLC6A9 P48067 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.40
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
HPGD P15428 2/20 0.40
HTT P42858 2/20 0.40
TP53 P04637 1/20 0.40
XBP1 P17861 1/20 0.40
HSD17B10 Q99714 1/20 0.40
AKR1C3 P42330 1/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
STAT3 P40763 1/20 0.40
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
PKM P14618 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089782 0.87 LMNA (0.43) MAPTLMNAL3MBTL1SLC6A9SMN1; SMN2
SCHEMBL6856708 0.79 MAPT (0.39) MAPTLMNAL3MBTL1SLC6A9SMN1; SMN2
SCHEMBL29510827 0.76 S1PR5 (0.56) MAPTLMNASMN1; SMN2RAB9ANPC1
SCHEMBL1462187 0.76 S1PR5 (0.56) MAPTLMNASMN1; SMN2RAB9ANPC1
SCHEMBL584781 0.74 SLC2A1 (0.56) MAPTSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL30280404 0.74 SLC2A1 (0.56) MAPTSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL3168485 0.73 CYP4F2 (0.51) MAPTL3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL6852995 0.72 KEAP1 (0.47) MAPTLMNAL3MBTL1SMN1; SMN2RAB9A
SCHEMBL6216285 0.72 ELANE (0.53) MAPTLMNAL3MBTL1HPGDHTT
SCHEMBL31535966 0.72 ALDH1A1 (0.45) MAPTLMNAL3MBTL1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030105078-A1 Diphenyl derivatives BAYER AKTIENGESSELLSCHAFT (DE) 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105078-A1 Diphenyl derivatives DPP4, DPP3, DPM1 MAPT 1592/4885LMNA 1567/4885L3MBTL1 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.